about
Distant Site Effects of Ingested PrebioticsEpidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative ReviewAlteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease StatusOptimizing methods and dodging pitfalls in microbiome researchAssociation between proton pump inhibitors and hepatic encephalopathy: A meta-analysis.Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management.Proton pump inhibitors: Risks of long-term use.Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.Machine Learning Meta-analysis of Large Metagenomic Datasets: Tools and Biological Insights.The Role of the Microbiome in Gastrointestinal Cancer.Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure.Delirium in the geriatric unit: proton-pump inhibitors and other risk factors.Nutritional Interventions for Gastroesophageal Reflux, Irritable Bowel Syndrome, and Hypochlorhydria: A Case ReportEffects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.Drug Exposure and the Risk of Microscopic Colitis: A Critical UpdateGlobal Fecal and Plasma Metabolic Dynamics Related to Helicobacter pylori Eradication.Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet.The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors.Patterns of Early-Life Gut Microbial Colonization during Human Immune Development: An Ecological PerspectiveSystematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.The microbiome-systemic diseases connection.European consensus conference on faecal microbiota transplantation in clinical practice.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.The esophageal microbiota in health and disease.Gut microbiome interactions with drug metabolism, efficacy, and toxicity.Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health.Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes.American Academy of Pain Medicine and Integrative Healthcare Symposium.The evolution of the host microbiome as an ecosystem on a leash.Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients.Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism.Proton-pump inhibitors: understanding the complications and risks.The gut microbiome in atherosclerotic cardiovascular disease.Does Long-Term Proton Pump Inhibitor Therapy Affect the Health of Gut Microbiota?Mirror, mirror on the wall: which microbiomes will help heal them all?The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study.
P2860
Q26738418-99059E27-658F-4E59-B50A-E30810124C04Q28073805-F60CF0C0-16FB-4FA4-9E54-EF780A61AA14Q28821054-704A5BED-4B0D-452B-B906-699F9D8A919FQ29994526-AF2463B5-1CAF-417D-918E-F77D38D5C59CQ30234653-7B801BD0-527F-4E63-AA1A-4B526E945083Q33879548-863128E5-A426-4AD3-A913-E038F35D324DQ34549406-498FD777-5059-4485-9E72-D84098374762Q36018079-E5528F2C-26C2-4F27-BDDC-00E49694C316Q36072739-5258D022-B9AA-45C8-8BAC-18694A6727CFQ36108718-F67EECC5-65BC-4EAC-9238-0BCA0C283FA3Q36318399-B925B78E-57ED-44E2-A020-3ACAC9C6E96DQ36786953-01626A36-6168-4E01-8B0D-69ED17DD5B8CQ37190734-44E0B963-990E-41D1-89BF-F3B40392AEDBQ37378692-F8AC7CDE-C763-4784-B6DB-9F5A3747965CQ37395942-2FDC0AF3-E622-4DAC-8FD6-6FCD48AA3572Q37653453-5F7E66ED-D2AE-4214-824E-C32990D8450BQ37727592-9D34E5E4-2002-4801-BE6A-4D2BE0EB32E8Q38617406-AE741D97-AB4E-4E61-8E3D-58991774AB8CQ38653409-49741E9A-A551-46FF-AEA7-27F76F1D7006Q38663368-E21276B0-638A-4071-8C05-47425F4F10F7Q38707449-6BFFF499-F8F5-4219-98DC-428537C08837Q38765160-1F6B0A95-F48B-4EB3-A1D7-30EB3B828345Q38770514-E45DAF67-5277-4285-9C07-0808838B134CQ38794312-066E1048-23AF-45C6-A88B-0CE2CB95EBCAQ38865456-AD892889-8CCB-44B0-9EE9-CFD8D00B0FF6Q38873800-23D28D40-EC4B-4117-B022-E1C2E72F392DQ38896455-82A3ECBE-4709-4E0D-A06B-828B570BE4A6Q38945423-794D336D-EB26-40E6-B526-F154095B1CF2Q39042753-40B27F83-523C-4930-BE85-80D7FEF48A21Q39227281-BC8896B2-3615-4788-AF3A-9D5D89B663D2Q39374045-5D1A16F7-BBD2-4A15-85A6-3776B25FB078Q39620870-74C97E23-D65D-40B1-A47A-73FA12CD68FEQ40108627-4D5E4F04-B09A-4BDE-BFC1-D59954D66D41Q41328388-D2406BB7-748F-4091-9118-1B57C2E2453FQ41336155-90A9001B-82EC-4246-8127-19F45C05D9FAQ41996131-C0F3465F-7BAA-41D2-BE89-ED60F9410FFFQ42265319-E21C232D-DEDE-4D87-BF7E-F4907418407EQ42377310-514F066E-25F7-45BF-B721-FAD8701CA4B3Q42562683-F129864F-5F49-4DBF-9EB5-7205D5EAB48EQ42700252-4330F174-B973-40C8-8328-27B295810E5F
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Proton pump inhibitors affect the gut microbiome.
@ast
Proton pump inhibitors affect the gut microbiome.
@en
type
label
Proton pump inhibitors affect the gut microbiome.
@ast
Proton pump inhibitors affect the gut microbiome.
@en
prefLabel
Proton pump inhibitors affect the gut microbiome.
@ast
Proton pump inhibitors affect the gut microbiome.
@en
P2093
P2860
P50
P1433
P1476
Proton pump inhibitors affect the gut microbiome.
@en
P2093
Alexandra Zhernakova
Daisy Jonkers
Ettje F Tigchelaar
Floris Imhann
Gerard Dijkstra
Hermie J M Harmsen
Ramnik J Xavier
Rinse K Weersma
Zlatan Mujagic
P2860
P304
P356
10.1136/GUTJNL-2015-310376
P407
P50
P577
2015-12-09T00:00:00Z